Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca AB) |
| BNF code | 1404000ATBNAAAU |
| Virtual Medicinal Product | Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials |
| Name | COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials |
| Abbreviated name | COVID-19 Vaccine AZD2816 AstraZeneca 0.5ml inj md vials |
| Supplier | AstraZeneca AB |
| Current licensing authority | None |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Clinical Trial |
| Actual Medicinal Product Packs | |
|---|---|
| COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca AB) 10 dose | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.